The use of anticonvulsants in the aftermath of mania

Journal of Psychopharmacology

Volumn 20, Issue 2 SUPPL., 2006, Pages 23-30

  Cookson, John ^a   Elliott, Brent ^b  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITAL LEWISHAM   (United Kingdom)

Author keywords

Anticonvulsant; Biopolar; Carbamazepine; Lamotrigine; Maintenance; Mania; Valporate

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; ETIRACETAM; FELBAMATE; GABAPENTIN; LAMOTRIGINE; LITHIUM; NEUROLEPTIC AGENT; OLANZAPINE; PHENYTOIN; PLACEBO; TIAGABINE; TOPIRAMATE; TRAZODONE; VALPROATE SEMISODIUM; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

ALCOHOLISM; ANXIETY; BIPOLAR DISORDER; BULIMIA; CEREBELLUM DISEASE; CLINICAL TRIAL; COMORBIDITY; CONFERENCE PAPER; CONFUSION; DEPRESSION; DRUG EFFICACY; DRUG USE; HEART ARRHYTHMIA; HUMAN; MAINTENANCE THERAPY; MANIA; MEDICAL PRACTICE; MENTAL PATIENT; MONOTHERAPY; NEUROLOGIC DISEASE; NEUROTOXICITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; UNSPECIFIED SIDE EFFECT;

ANTICONVULSANTS; ANTIMANIC AGENTS; BIPOLAR DISORDER; DRUG THERAPY, COMBINATION; HUMANS; LITHIUM CARBONATE; LONG-TERM CARE; RECURRENCE; TREATMENT OUTCOME;

EID: 33645098029     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/1359786806063073     Document Type: Conference Paper

References (49)

1. Baethge C, Baldessarini R J, Mathiske-Schmidt K, Hennen J, Berghöfer A, Müller-Oerlinghausen B, Bschor T, Adli M, Bauer M (2005) Long-term combination therapy versus monotherapy with lithium and carbamazepine in 46 bipolar I patients. J Clin Psychiatry 66: 174-182
2. Ballenger J C, Post R M (1980) Carbamazepine in manic depressive illness: a new treatment. American Journal of Psychiatry 137: 782-790
3. Bowden C L, Singh V (2005) Valproate in bipolar disorder: 2000 onwards. Acta Psychitar Scand 111 (Suppl. 426): 13-20
4. Bowden C L, Brugger A M, Swann A C (1994) Efficacy of divalproex vs. lithium and placebo in the treatment of mania. Journal of the American Medical Association 271: 918-924
5. Bowden C L, Calabrese J R, McElroy S L, Gyulai L, Wassef A, Petty F (2000) A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group. Arch Gen Psychiatry 57(5): 481-489
6. Bowden C L, Calabrese J R, Sachs G, Yatham L N, Asghar S A, Hompland M, Montgomery P, Earl N, Smoot TM, DeVeaugh-Geiss J (2003) A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry 60(4): 392-400
7. Calabrese J R, Delucchi G A (1990) Spectrum of efficacy of valproate in 55 patients with rapid cycling bipolar disorder. Am J Psychiatry 147: 431-434
8. Calabrese J R, Suppes T, Bowden C L, Sachs G S, Swann A C, McElroy S L, Kusumakar V, Ascher J A, Earl H L, Greene P L, Monaghan E T (2000) A double blind placebo controlled, prophylaxis study of lamotrigine in rapid cycling bipolar disorder. J Clin Psychiatry 61: 841-850
9. Calabrese J R, Bowden C L, Sachs G, Yatham L N, Behnke K, Mehtonen O P (2003) A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J Clin Psychiatry 64: 1013-1024
10. Calabrese J, Shelton M, Rapport D, Youngstrom E, Shirley E, Elhaj O, Packer K, Bilali S, Findling R (2005) A 20 month, double-blind, maintenance trial of lithium versus divalproex in rapid cycling bipolar disorder. Am J Psychiatry 162: 2151-2161
11. Dardennes R, Even C, Bange F, Heim A (1995) A comparison of carbamazepine and lithium in the prophylaxis of bipolar disorders: a meta-analysis. British Journal of Psychiatry 766: 378-381
12. Davis J M, Janicack P G, Hogan D M (1999) Mood stabilsers in the prevention of recurrent affective disorder: a meta-analysis. Acta Psychiatrica Scandinavica 100: 406-417
13. Denicoff K D, Smith-Jackson E E, Disney E R, Omar Ali S, Leverich G S, Post R M (1997) Comparative prophylactic efficacy of lithium, carbamazepine and the combination in bipolar disorder. J Clin Psychiatry 58: 470-478
14. Freeman M P, Stoll A L (1998) Mood stabilizer combinations: a review of safety and efficacy. American Journal of Psychiatry 155: 12-21
15. Frye M A, Ketter T A, Kimbrell T A (2000) A placebo controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. J Clin Psychopharmacol 20(6): 607-614
16. Goldberg J F, Garno J L, Leon A C, Kocsis J H, Portera L (1999) A history of substance abuse complicates remission from acute mania in bipolar disorder. J Clin Psychiatry 60: 733-740
17. Goodwin G M (2003) Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 17: 149-173
18. Goodwin F K, Fireman B, Simon G E, Hunkeler E M, Lee J, Revicki D (2003) Suicide risk in bipolar disorder during treatment with lithium and divalproex. JAMA 17(290): 1467-1473
19. Goodwin G, Bowden C, Calabrese J, Grunze H, Kasper S, White R, Greene P, Leadbetter R (2004) A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. J Clin Psychiatry 65: 432-441
20. Greil W, Kleindienst N (1999a) Lithium versus carbamazepine in the maintenance treatment of bipolar II disorder and bipolar disorder not otherwise specified. Int Clin Psychopharmacol 14: 283-285
21. Greil W, Kleindienst N (1999b) The comparative prophylactic efficacy of lithium and carbamazepine in patients with bipolar I disorder. Int Clin Psychopharmacol 14: 277-281
22. Greil W, Kleindienst N, Erazo N, Müller-Oerlinghausen B (1998) Differential response to lithium and carbamazepine in the prophylaxis of bipolar disorder. J Clin Psychopharmacol 18: 455-460
23. Hartong E G Th M, Moleman P, Hoogduin C A L, Broekman T G, Nolen W A, Lit Car Group (2003) Prophylactic efficacy of lithium versus carbamazepine in treatment-naïve bipolar patients. J Clin Psychiatry 64: 144-151
24. Hedges D W, Reimherr F W, Hoopes S P, Rosenthal N R, Kamin M, Karim R, Capece J A (2003) Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 2: improvement in psychiatric measures. J Clin Psychiatry 64: 1449-1454
25. Hoopes S P, Reinherr F W, Hedges D W, Rosenthal N R, Kamin M, Karim R, Capece J A, Karvois D (2003) Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 1: improvement in binge and purge measures. J Clin Psychiatry 64: 1335-1341
26. Kramlinger K G, Post R M (1989) Adding lithium carbonate to carbamazepine: anti-manic efficacy in treatment-resistant mania. Acta Psychiatrica Scandrnavica 79: 378-385
27. Johnson B A, Ait-Daoud N, Bowden C L, DiClemente C C, Roache J D, Lawson K, Javors M A, Ma J Z (2003) Oral topiramate for treatment of alcohol dependence: a randomised controlled trial. Lancet 361(9370): 1677-1685
28. Licht R W, Vestergaard P, Kessing L V, Larsen J K, Thomsen P H (2003) Psychopharmacological treatment with lithium and antiepileptic drugs: suggested guidelines from the Danish Psychiatric Association and the Child and Adolescent Psychiatric Association in Denmark. Acta Psychiatr Scand 108 (Suppl. 419): 1-22
29. Muzina D J, Elhaj O, Gajwani P, Gao K, Calabrese J R (2005) Lamotrigine and antiepileptic drugs as mood stabilisers in bipolar disorders. Acta Psych Scand 111 (Suppl. 426): 21-28
30. Nolen W A, Knoppert-van der Klein E A M, Honig A, Bouvy P F, Klompenhouwer J-L, De Witt A, Ravelli D P (2001) Richtlijn bipolaire stoornissen (Guideline Bipolar disorders). Boom Publishers, Amsterdam
31. Okuma T, Kishimoto A, Inoue K, Matumoto A, Ogura A, Matsushita T, Nakao T, Ogura C (1973) Anti-manic and prophylactic effects of carbamazepine (Tegretol) on manic depressive psychosis: a preliminary report. Folia Psychiatrica Neurology Japan 27: 283-297
32. Okuma T, Inanaga K, Otsuki S, Sarai K, Takahashi H, Mori A, Watanabe M (1981) A preliminary double-blind study of carbamazepine in prophylaxis of manic-depressive illness. Psychopharmacology 73: 95-96
33. Pande A C, Crockatt J G, Janney C A, Werth J L, Tsaroucha G (2000) Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group. Bipolar Disord 2(3 Pt 2): 249-255
34. Pande A C, Davidson J R, Jefferson J W, Janney C A, Katzelnick D J, Weisler R H, Greist J H, Sutherland S M (1999) Treatment of social phobia with gabapentin: a placebo-controlled study. J Clin Psychopharmacol 19(4): 341-348
35. Post R M (1990) Prophylaxis of bipolar disorders. International Review of Psychiatry 2: 227-320
36. Post R M (1992) Trans-duction of psychosocial stress into the neurobiology of recurrent affective disorder. American Journal of Psychiatry 149: 999-1010
37. Post R M, Uhde T W, Ballenger J C, Squillace K M (1983) Prophylactic efficacy of carbamazepine in manic-depressive illness. American Journal of Psychiatry 140: 1602-1604
38. Prien R F, Gelenberg A J (1989) Alternatives to lithium for preventive treatment of bipolar disorder. American Journal of Psychiatry 146: 840-848
39. Prien R F, Caffey E M Jr, Klett C J (1973) Prophylactic efficacy of lithium carbonate in manic-depressive illness. Archives of General Psychiatry 28: 337-341
40. Rendell J M, Juszczak E, Hainsworth J, Gucht E V, Healey C, Morriss R, Ferrier N, Young A H, Young H, Goodwin G M, Geddes J R (2004) Developing the BALANCE trail - the role of the pilot study and start-up phase. Bipolar Disord 6: 26-31. Review. Erratum in: Bipolar Disord 6: 170
41. Salloum I M, Cornelius J R, Daley D C, Kirisci L, Himmelhoch J M, Thase M E (2005) Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study. Arch Gen Psychiatry 62: 37-45
42. Shukla S, Godwin C D, Long L E B, Miller M G (1985) Lithium-carbamazepine neurotoxicity and risk factors. American Journal of Psychiatry 141: 1604-1606
43. Solomon D A, Ryan C E, Keitner G I, Miller I W (1997) A pilot study of lithium carbonate plus divalproex sodium for the continuation and maintenance treatment of patients with bipolar I disorder. Journal of Clinical Psychiatry 58: 95-99
44. Steekler T L (1994) Lithium- and carbamazepine-associated sinus node dysfunction: nine-year experience in a psychiatric hospital. Journal of Clinical Psychopharmacology 14: 336-339
45. Suppes T, Dennehy E B, Hirschfeld R M A, Altshuler L L, Bowden C L, Calabrese J R, Crismon M L, Ketter T A, Sachs G S, Swann A C for the Texas Consensus Conference Panel on Medication Treatment of Bipolar Disorder (2005) The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar-I disorder. J Clin Psychiatry 66: 870-886
46. Tohen M, Baker R W, Altshuler L L, Zarate C A, Suppes T, Ketter T A, Milton D R, Risser R, Gilmore J A, Breier A, Tollefson G A (2002) Olanzapine versus divalproex in the treatment of acute mania. Am J Psychiatry 159: 1011-1017
47. Tohen M, Ketter T A, Zarate C A, Suppes T, Frye M, Altshuler L, Zajecka J, Schuh L M, Risser R C, Brown E, Baker R W (2003) Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47 week study. Am J Psychiatry 160: 1263-1271
48. Yatham L N, Kennedy S H, O'Donovan C, Parikh S, MacQueen G, McIntyre R, Sharma V, Silverstone P, Alda M, Baruch P, Beaulieu S, Daigneault A, Milev R, Young T, Ravindran A, Schaffer A, Connolly M, Gorman C P (2005) Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies. Bipolar Disord 7 (Suppl. 3): 5-69
49. Zajecka J M, Weisler R, Sachs G, Swann A C, Wozniak P, Sommerville K W (2002) A comparison of the efficacy, safety, and tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorder. J Clin Psychiatry 63: 1148-1155